Clinical Trials Browser

Phase 3 × Brain Neoplasms × Corticotropin-Releasing Hormone × Clear all

NCT00088166 2014-08-13

XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors

Phase 3 Completed

200 enrolled 17 charts

Astrocytoma, Brain Edema, Brain Neoplasms, Edema

NCT00226655 2012-08-31

An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated Studies

Phase 3 Completed

112 enrolled 8 charts

Astrocytoma, Brain Edema, Brain Neoplasms, Edema

NCT00226668 2008-01-03

XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema

Phase 3 Withdrawn

Astrocytoma, Brain Edema, Brain Neoplasms, Edema